September 2007
Lutein & Zeaxanthin: Lowering AMD Risk
Lutein and zeaxanthin has again been linked to lowering the risk of neovascular AMD. Researchers studied 4,519 Age-Related Eye Disease Study (AREDS) participants between 60 and 80 years of age.  They found that carotenoids, lutein and zeaxanthin, absorb blue light that could damage the macula, by preventing free radicals from damaging eye cells and by strengthening eye cell membranes.*

This study, published in Archives of Ophthalmology, concluded  that a higher intake of Lutein and zeaxanthin may help lower the risk for AMD.  

Lutein and zeaxanthin is available in Viteyes® Essentials with 15 mg of FloraGlo® lutein and 4.75 mg of OPTISHARP® zeaxanthin.  Lutein and zeaxanthin are also found as part of the following formulas: Viteyes® Complete (a premium multivitamin) and Viteyes® AREDS Plus Lutein, Viteyes® AREDS Advanced, Viteyes® Plus Lutein Beta-Carotene Free and Viteyes® Advanced Beta-Carotene Free. To order please call 1-800-890-EYES (3937) or go online at www.viteyes.com.

*Age-Related Eye Disease Study Research Group. Archives of Ophthalmology. “The Relationship of Dietary Carotenoid and Vitamin A, E and C Intake With Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22.” Volume 125:1225-1232. September 2007.

 << Back to Newsroom